PDF factsheet
      Z

bioresorbable vascular scaffold in percutaneous coronary intervention for all type of patients, clinical trials results

(Absorb, Abbott Vascular, versus everolimus-eluting metallic stent
ABSORB II,
NCT01425281
everolimus-eluting bioresorbable scaffold (Absorb, Abbott Vascular)
versus
everolimus-eluting metallic stent (Xience, Abbott Vascular)
patients aged 18-85 years with evidence of myocardial ischaemia and one or two de-novo native lesions in different epicardial vesselssingle blind
Follow-up duration: 1 year analysis
biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent
BIOFLOW-V, 0
NCT02389946
Ultrathin strut biodegradable polymer sirolimus-eluting stent
versus
durable polymer everolimus-eluting stent
patients aged 18 years or older with chronic stable coronary artery disease or acute coronary syndromes undergoing percutaneous coronary intervention
Switzerland

  Options


in first

in second

  Filter